{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T06:09:41Z","timestamp":1772172581867,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1008066","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000}}],"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>\n                    Cancer treatments can be highly toxic and frequently only a subset of the patient population will benefit from a given treatment. Tumour genetic makeup plays an important role in cancer drug sensitivity. We suspect that gene expression markers could be used as a decision aid for treatment selection or dosage tuning. Using\n                    <jats:italic>in vitro<\/jats:italic>\n                    cancer cell line dose-response and gene expression data from the Genomics of Drug Sensitivity in Cancer (GDSC) project, we build a dose-varying regression model. Unlike existing approaches, this allows us to estimate dosage-dependent associations with gene expression. We include the transcriptomic profiles as dose-invariant covariates into the regression model and assume that their effect varies smoothly over the dosage levels. A two-stage variable selection algorithm (variable screening followed by penalized regression) is used to identify genetic factors that are associated with drug response over the varying dosages. We evaluate the effectiveness of our method using simulation studies focusing on the choice of tuning parameters and cross-validation for predictive accuracy assessment. We further apply the model to data from five\n                    <jats:italic>BRAF<\/jats:italic>\n                    targeted compounds applied to different cancer cell lines under different dosage levels. We highlight the dosage-dependent dynamics of the associations between the selected genes and drug response, and we perform pathway enrichment analysis to show that the selected genes play an important role in pathways related to tumorigenesis and DNA damage response.\n                  <\/jats:p>","DOI":"10.1371\/journal.pcbi.1008066","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T13:55:31Z","timestamp":1611582931000},"page":"e1008066","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["A regularized functional regression model enabling transcriptome-wide dosage-dependent association study of cancer drug response"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6545-911X","authenticated-orcid":true,"given":"Evanthia","family":"Koukouli","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0068-1005","authenticated-orcid":true,"given":"Dennis","family":"Wang","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1816-6300","authenticated-orcid":true,"given":"Frank","family":"Dondelinger","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7112-6493","authenticated-orcid":true,"given":"Juhyun","family":"Park","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2021,1,25]]},"reference":[{"issue":"9381","key":"pcbi.1008066.ref001","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0140-6736(03)14023-8","article-title":"Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer","volume":"362","author":"JC Chang","year":"2003","journal-title":"The Lancet"},{"issue":"6","key":"pcbi.1008066.ref002","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrd4309","article-title":"Lessons learned from the fate of AstraZeneca\u2019s drug pipeline: a five-dimensional framework","volume":"13","author":"D Cook","year":"2014","journal-title":"Nature Reviews Drug Discovery"},{"issue":"1","key":"pcbi.1008066.ref003","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.mpmed.2007.10.012","article-title":"Cytotoxic chemotherapy: clinical aspects","volume":"36","author":"PG Corrie","year":"2008","journal-title":"Medicine"},{"issue":"2","key":"pcbi.1008066.ref004","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/35101056","article-title":"Pharmacogenetics and cancer therapy","volume":"1","author":"MV Relling","year":"2001","journal-title":"Nature Reviews Cancer"},{"issue":"3","key":"pcbi.1008066.ref005","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.celrep.2013.07.010","article-title":"Integrating genomic, epigenomic, and transcriptomic features reveals modular signatures underlying poor prognosis in ovarian cancer","volume":"4","author":"W Zhang","year":"2013","journal-title":"Cell Reports"},{"issue":"3","key":"pcbi.1008066.ref006","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","article-title":"A landscape of pharmacogenomic interactions in cancer","volume":"166","author":"F Iorio","year":"2016","journal-title":"Cell"},{"issue":"D1","key":"pcbi.1008066.ref007","doi-asserted-by":"crossref","first-page":"D955","DOI":"10.1093\/nar\/gks1111","article-title":"Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"W Yang","year":"2012","journal-title":"Nucleic Acids Research"},{"issue":"4","key":"pcbi.1008066.ref008","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.cell.2016.12.015","article-title":"Implementing genome-driven oncology","volume":"168","author":"DM Hyman","year":"2017","journal-title":"Cell"},{"key":"pcbi.1008066.ref009","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41586-018-0409-3","article-title":"Genetic and transcriptional evolution alters cancer cell line drug response","volume":"560","author":"U Ben-David","year":"2018","journal-title":"Nature"},{"issue":"8","key":"pcbi.1008066.ref010","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/1878-0261.12521","article-title":"Genomic signatures defining responsiveness to allopurinol and combination therapy for lung cancer identified by systems therapeutics analyses","volume":"13","author":"I Tavassoly","year":"2019","journal-title":"Molecular Oncology"},{"issue":"9","key":"pcbi.1008066.ref011","article-title":"Transcriptional profiling of the dose response: a more powerful approach for characterizing drug activities","volume":"5","author":"RR Ji","year":"2009","journal-title":"PLoS Computational Biology"},{"issue":"11","key":"pcbi.1008066.ref012","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1158\/1535-7163.MCT-16-0297","article-title":"Identification of pharmacodynamic transcript biomarkers in response to FGFR inhibition by AZD4547","volume":"15","author":"O Delpuech","year":"2016","journal-title":"Molecular Cancer Therapeutics"},{"issue":"10","key":"pcbi.1008066.ref013","doi-asserted-by":"crossref","first-page":"e1003293","DOI":"10.1371\/journal.pcbi.1003293","article-title":"Dynamic rendering of the heterogeneous cell response to anticancer treatments","volume":"9","author":"F Falcetta","year":"2013","journal-title":"PLoS Computational Biology"},{"issue":"4","key":"pcbi.1008066.ref014","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1158\/0008-5472.CAN-16-1578","article-title":"Cell-specific computational modeling of the PIM pathway in acute myeloid leukemia","volume":"77","author":"D Silverbush","year":"2017","journal-title":"Cancer Research"},{"key":"pcbi.1008066.ref015","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41540-019-0113-4","article-title":"Defining subpopulations of differential drug response to reveal novel target populations","volume":"5","author":"N Keshava","year":"2019","journal-title":"NPJ Systems Biology and Applications"},{"issue":"4","key":"pcbi.1008066.ref016","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.2517-6161.1993.tb01939.x","article-title":"Varying-coefficient models","volume":"55","author":"T Hastie","year":"1993","journal-title":"Journal of the Royal Statistical Society: Series B (Methodological)"},{"issue":"444","key":"pcbi.1008066.ref017","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1080\/01621459.1998.10473800","article-title":"Asymptotic confidence regions for kernel smoothing of a varying-coefficient model with longitudinal data","volume":"93","author":"CO Wu","year":"1998","journal-title":"Journal of the American Statistical Association"},{"key":"pcbi.1008066.ref018","first-page":"433","article-title":"Kernel smoothing on varying coefficient models with longitudinal dependent variable","author":"CO Wu","year":"2000","journal-title":"Statistica Sinica"},{"key":"pcbi.1008066.ref019","first-page":"763","article-title":"Polynomial spline estimation and inference for varying coefficient models with longitudinal data","author":"JZ Huang","year":"2004","journal-title":"Statistica Sinica"},{"issue":"2","key":"pcbi.1008066.ref020","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1541-0420.2005.00490.x","article-title":"Quadratic inference functions for varying-coefficient models with longitudinal data","volume":"62","author":"A Qu","year":"2006","journal-title":"Biometrics"},{"issue":"494","key":"pcbi.1008066.ref021","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1198\/jasa.2011.tm09779","article-title":"Nonparametric independence screening in sparse ultra-high-dimensional additive models","volume":"106","author":"J Fan","year":"2011","journal-title":"Journal of the American Statistical Association"},{"key":"pcbi.1008066.ref022","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1214\/09-SS049","article-title":"Curse of dimensionality and related issues in nonparametric functional regression","volume":"5","author":"G Geenens","year":"2011","journal-title":"Statistics Surveys"},{"issue":"4","key":"pcbi.1008066.ref023","first-page":"1735","article-title":"On varying-coefficient independence screening for high-dimensional varying-coefficient models","volume":"24","author":"R Song","year":"2014","journal-title":"Statistica Sinica"},{"issue":"2","key":"pcbi.1008066.ref024","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1214\/16-AOAS912","article-title":"Feature screening for time-varying coefficient models with ultrahigh dimensional longitudinal data","volume":"10","author":"W Chu","year":"2016","journal-title":"The Annals of Applied Statistics"},{"issue":"507","key":"pcbi.1008066.ref025","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1080\/01621459.2013.879828","article-title":"Nonparametric independence screening in sparse ultra-high-dimensional varying coefficient models","volume":"109","author":"J Fan","year":"2014","journal-title":"Journal of the American Statistical Association"},{"key":"pcbi.1008066.ref026","doi-asserted-by":"crossref","unstructured":"Wang D, Hensman J, Kukaite G, Toh TS, Dry JR, Saez-Rodriguez J, et al. A statistical framework for assessing pharmacological response and biomarkers with confidence. BioRxiv. 2020.","DOI":"10.1101\/2020.05.01.072983"},{"key":"pcbi.1008066.ref027","unstructured":"Tansey W, Li K, Zhang H, Linderman SW, Rabadan R, Blei DM, et al. Dose-response modeling in high-throughput cancer drug screenings: An end-to-end approach. arXiv preprint arXiv:181205691. 2018."},{"issue":"492","key":"pcbi.1008066.ref028","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1198\/jasa.2010.tm10128","article-title":"Consistent model selection for marginal generalized additive model for correlated data","volume":"105","author":"L Xue","year":"2010","journal-title":"Journal of the American Statistical Association"},{"issue":"Jun","key":"pcbi.1008066.ref029","first-page":"1973","article-title":"Variable selection in high-dimensional varying-coefficient models with global optimality","volume":"13","author":"L Xue","year":"2012","journal-title":"Journal of Machine Learning Research"},{"issue":"12","key":"pcbi.1008066.ref030","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/nmeth.4077","article-title":"OmniPath: guidelines and gateway for literature-curated signaling pathway resources","volume":"13","author":"D T\u00fcrei","year":"2016","journal-title":"Nature Methods"},{"issue":"20","key":"pcbi.1008066.ref031","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1038\/s41388-020-1274-8","article-title":"Nuclear DLC1 exerts oncogenic function through association with FOXK1 for cooperative activation of MMP9 expression in melanoma","volume":"39","author":"X Yang","year":"2020","journal-title":"Oncogene"},{"issue":"1","key":"pcbi.1008066.ref032","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JCO.2017.73.6785","article-title":"Dabrafenib and trametinib treatment in patients with locally advanced or metastatic BRAF V600\u2013mutant anaplastic thyroid cancer","volume":"36","author":"V Subbiah","year":"2018","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"pcbi.1008066.ref033","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/S1470-2045(12)70046-3","article-title":"RAS mutations and the development of secondary tumours in patients given BRAF inhibitors","volume":"13","author":"SP Sharma","year":"2012","journal-title":"The Lancet Oncology"},{"issue":"1","key":"pcbi.1008066.ref034","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2105-14-128","article-title":"Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool","volume":"14","author":"EY Chen","year":"2013","journal-title":"BMC Bioinformatics"},{"issue":"W1","key":"pcbi.1008066.ref035","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"MV Kuleshov","year":"2016","journal-title":"Nucleic Acids Research"},{"issue":"D1","key":"pcbi.1008066.ref036","doi-asserted-by":"crossref","first-page":"D661","DOI":"10.1093\/nar\/gkx1064","article-title":"WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research","volume":"46","author":"DN Slenter","year":"2017","journal-title":"Nucleic Acids Research"},{"issue":"2","key":"pcbi.1008066.ref037","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tcb.2005.12.005","article-title":"Osteopontin: role in cell signaling and cancer progression","volume":"16","author":"H Rangaswami","year":"2006","journal-title":"Trends in Cell Biology"},{"issue":"9","key":"pcbi.1008066.ref038","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s00018-015-2123-8","article-title":"NLR-regulated pathways in cancer: opportunities and obstacles for therapeutic interventions","volume":"73","author":"N Sharma","year":"2016","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"5","key":"pcbi.1008066.ref039","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/bcr2361","article-title":"Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development","volume":"11","author":"J Whyte","year":"2009","journal-title":"Breast Cancer Research"},{"issue":"8","key":"pcbi.1008066.ref040","doi-asserted-by":"crossref","first-page":"12537","DOI":"10.1002\/jcp.28122","article-title":"Mechanisms of apoptosis modulation by curcumin: Implications for cancer therapy","volume":"234","author":"K Mortezaee","year":"2019","journal-title":"Journal of Cellular Physiology"},{"issue":"4","key":"pcbi.1008066.ref041","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.molcel.2019.05.036","article-title":"IKK\u03b1 kinase regulates the DNA damage response and drives chemo-resistance in cancer","volume":"75","author":"C Colomer","year":"2019","journal-title":"Molecular Cell"},{"issue":"43","key":"pcbi.1008066.ref042","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"A Subramanian","year":"2005","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"1","key":"pcbi.1008066.ref043","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Y Benjamini","year":"1995","journal-title":"Journal of the Royal Statistical Society: Series B (Statistical Methodology)"},{"issue":"6","key":"pcbi.1008066.ref044","doi-asserted-by":"crossref","first-page":"e1002572","DOI":"10.1371\/journal.pcbi.1002572","article-title":"Bringing molecules back into molecular evolution","volume":"8","author":"CO Wilke","year":"2012","journal-title":"PLoS Computational Biology"},{"issue":"D1","key":"pcbi.1008066.ref045","first-page":"D498","article-title":"The reactome pathway knowledgebase","volume":"48","author":"B Jassal","year":"2020","journal-title":"Nucleic Acids Research"},{"issue":"5","key":"pcbi.1008066.ref046","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1084\/jem.20131780","article-title":"B-RAF kinase drives developmental axon growth and promotes axon regeneration in the injured mature CNS","volume":"211","author":"KJ O\u2019Donovan","year":"2014","journal-title":"Journal of Experimental Medicine"},{"issue":"2","key":"pcbi.1008066.ref047","doi-asserted-by":"crossref","first-page":"219","DOI":"10.15252\/emmm.201505774","article-title":"VEGF blockade enhances the antitumor effect of BRAFV 600E inhibition","volume":"9","author":"V Comunanza","year":"2017","journal-title":"EMBO Molecular Medicine"},{"issue":"8","key":"pcbi.1008066.ref048","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1056\/NEJMcibr1013704","article-title":"Resistance to BRAF inhibition in melanomas","volume":"364","author":"DB Solit","year":"2011","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"pcbi.1008066.ref049","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2016.06.07","article-title":"Resistant mechanisms to BRAF inhibitors in melanoma","volume":"4","author":"JL Manzano","year":"2016","journal-title":"Annals of Translational Medicine"},{"issue":"5","key":"pcbi.1008066.ref050","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nbt1397","article-title":"A modular approach for integrative analysis of large-scale gene-expression and drug-response data","volume":"26","author":"Z Kutalik","year":"2008","journal-title":"Nature Biotechnology"},{"issue":"11","key":"pcbi.1008066.ref051","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/bioinformatics\/btw059","article-title":"Integrative analysis for identifying joint modular patterns of gene-expression and drug-response data","volume":"32","author":"J Chen","year":"2016","journal-title":"Bioinformatics"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1008066","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1008066","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T19:49:45Z","timestamp":1724356185000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1008066"}},"subtitle":[],"editor":[{"given":"Avner","family":"Schlessinger","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2021,1,25]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1008066","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.06.18.158907","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,25]]}}}